Rupert C. Ecker
Dr. Rupert Ecker has been co-founder of the TissueGnostics group in Austria, Romania, USA and Asia-Pacific. He is Chief Executive Officer of TissueGnostics GLOBAL.
Before founding TissueGnostics he was a research scientist at the Competence Centre for Bio Molecular Therapeutics in Vienna, a joint venture between the University of Vienna and the Novartis Research Institute Vienna.
As a co-inventor of the TissueFAXS technology Rupert Ecker has always been significantly involved in research and (product) development from system design to clinical testing and has successfully headed several joint R&D projects with academic partner institutions in the fields of advanced computer vision, cancer research, stem cell biology, and personalized medicine.
Rupert Ecker graduated in Cell Biology from the University of Vienna. He has more than 25 years of experience in microscopy and image analysis. In addition, he has been trained in software development.
Since August 2021 Rupert Ecker holds an honorary appointment as Adjunct Professor at the Faculty of Health, School of Biomedical Sciences, Queensland University of Technology where he works on artificial intelligence (AI)-based decision support systems for next-generation histopathology / tissue cytometry.
Abstracts this author is presenting: